Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 03 2023
Historique:
received: 22 11 2022
accepted: 10 03 2023
entrez: 22 3 2023
pubmed: 23 3 2023
medline: 24 3 2023
Statut: epublish

Résumé

This study evaluates the functional capacity of CD4

Identifiants

pubmed: 36944716
doi: 10.1038/s41598-023-31347-8
pii: 10.1038/s41598-023-31347-8
pmc: PMC10028771
doi:

Substances chimiques

sinovac COVID-19 vaccine 0
COVID-19 Vaccines 0
Aluminum CPD4NFA903
Programmed Cell Death 1 Receptor 0
Adjuvants, Immunologic 0

Types de publication

Randomized Controlled Trial Clinical Trial, Phase III Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4610

Informations de copyright

© 2023. The Author(s).

Références

Nat Med. 2021 Feb;27(2):270-278
pubmed: 33335323
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
Mol Biol Rep. 2022 Jun;49(6):4943-4957
pubmed: 35235159
Lancet. 2020 Sep 26;396(10255):887-897
pubmed: 32896291
Nat Commun. 2022 Jun 28;13(1):3700
pubmed: 35764637
Hum Vaccin Immunother. 2019;15(2):407-411
pubmed: 30277831
Sci Immunol. 2020 Dec 22;5(54):
pubmed: 33443036
Eur J Immunol. 2018 Apr;48(4):705-715
pubmed: 29349774
Vaccines (Basel). 2022 May 30;10(6):
pubmed: 35746486
J Virol. 2020 Sep 29;94(20):
pubmed: 32759313
Nat Commun. 2021 Mar 19;12(1):1724
pubmed: 33741972
Front Immunol. 2020 Mar 24;11:487
pubmed: 32265932
Virus Res. 2020 Oct 15;288:198114
pubmed: 32800805
Immunity. 2018 Feb 20;48(2):214-226
pubmed: 29466754
N Engl J Med. 2021 Jun 17;384(24):2352-2354
pubmed: 33826819
Front Immunol. 2019 Jul 02;10:1400
pubmed: 31312199
Springerplus. 2015 Apr 16;4:181
pubmed: 25932368
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
Nat Rev Immunol. 2020 Sep;20(9):529-536
pubmed: 32728222
Cell Rep. 2014 Sep 11;8(5):1318-27
pubmed: 25199826
Nat Commun. 2021 Jun 30;12(1):4043
pubmed: 34193870
Front Immunol. 2013 Jan 10;3:406
pubmed: 23335921
Lancet. 2021 Jul 17;398(10296):213-222
pubmed: 34246358
Nat Rev Immunol. 2021 Feb;21(2):73-82
pubmed: 33340022
Cell. 2020 Oct 1;183(1):13-15
pubmed: 32976799
Immunity. 2021 Sep 14;54(9):2133-2142.e3
pubmed: 34453880
Cell Rep. 2022 Feb 22;38(8):110399
pubmed: 35139367
Nat Rev Immunol. 2020 Oct;20(10):615-632
pubmed: 32887954
Transpl Immunol. 2022 Feb;70:101495
pubmed: 34774738
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
Front Immunol. 2013 May 16;4:114
pubmed: 23720661
Emerg Microbes Infect. 2020 Dec;9(1):940-948
pubmed: 32357808
Vaccines (Basel). 2018 Dec 14;6(4):
pubmed: 30558246
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Science. 2021 Jun 4;372(6546):1108-1112
pubmed: 33947773
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
Cell Immunol. 2021 Jul;365:104363
pubmed: 33905951
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
J Clin Invest. 2020 Sep 1;130(9):4694-4703
pubmed: 32463803
Nat Rev Immunol. 2021 Mar;21(3):131-132
pubmed: 33402727
Front Immunol. 2014 Apr 16;5:171
pubmed: 24795718
Nat Immunol. 2022 Mar;23(3):360-370
pubmed: 35210622
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
Lancet Infect Dis. 2021 Jul;21(7):950-961
pubmed: 33705727
Front Immunol. 2021 Jul 12;12:701501
pubmed: 34322129
Geroscience. 2021 Oct;43(5):2321-2331
pubmed: 34633612
medRxiv. 2021 Apr 01;:
pubmed: 35441164
mBio. 2022 Jun 28;13(3):e0018122
pubmed: 35475648
Nature. 2021 Aug;596(7873):495-504
pubmed: 34237771
Pharmaceuticals (Basel). 2021 Apr 25;14(5):
pubmed: 33923054
J Immunol. 1992 Feb 15;148(4):1143-8
pubmed: 1737931
Cytokine Growth Factor Rev. 2016 Oct;31:73-81
pubmed: 27502919
Annu Rev Immunol. 2004;22:745-63
pubmed: 15032595
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Sci Rep. 2022 Jun 16;12(1):10125
pubmed: 35710573
N Engl J Med. 2021 Jun 17;384(24):2354-2356
pubmed: 33822491

Auteurs

Ece Tavukcuoglu (E)

Department of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.

Hamdullah Yanik (H)

Department of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.

Mubaida Parveen (M)

Department of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.

Sila Uluturk (S)

Department of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.

Mine Durusu-Tanriover (M)

Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Ahmet Cagkan Inkaya (AC)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Murat Akova (M)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Serhat Unal (S)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Gunes Esendagli (G)

Department of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey. gunese@hacettepe.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH